Premium
Polydimethylsiloxane/nano calcium phosphate composite tracheal stents: Mechanical and physiological properties
Author(s) -
Bendo Demétrio Kétner,
Giotti Cioato Marta Justina,
Moreschi Alexandre,
Oliveira Guilherme Augusto,
Lorenzi William,
Hehn de Oliveira Francine,
Vieira de Macedo Neto Amarílio,
Stefani Sanches Paulo Roberto,
Xavier Rogerio Gastal,
Loureiro dos Santos Luís Alberto
Publication year - 2019
Publication title -
journal of biomedical materials research part b: applied biomaterials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.665
H-Index - 108
eISSN - 1552-4981
pISSN - 1552-4973
DOI - 10.1002/jbm.b.34145
Subject(s) - materials science , polydimethylsiloxane , biomaterial , calcium , in vivo , composite material , matrix (chemical analysis) , molding (decorative) , biomedical engineering , composite number , ultimate tensile strength , nanoparticle , in situ , chemical engineering , nanotechnology , organic chemistry , medicine , chemistry , microbiology and biotechnology , engineering , metallurgy , biology
In this study, we report the production and characterization of tracheal stents composed of polydimethylsiloxane/nanostructured calcium phosphate composites obtained by reactive synthesis. Tracheal stents were produced by transfer molding, and in vivo tests were carried out. PDMS was combined with H 3 PO 4 and Ca(OH) 2 via an in situ reaction to obtain nanoparticles of calcium phosphate dispersed within the polymeric matrix. The incorporation of bioactive inorganic substances, such as calcium phosphates, improved biological properties, and the in situ reaction allowed tight coupling of particles to the matrix. Results showed the presence of the nanoparticles of DCPA and CDHA. The porosity generated during mixing decreased the tensile strength and tear properties. Composites presented higher values of cell viability compared with those for PDMS. In vivo tests indicated the presence of inflammatory tissue 30 days after implantation in both cases. Thus, the present biomaterial shows potential for application in tracheal disease, however further evaluation is needed. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2018. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 545–553, 2019.